E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation
- 22 February 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (8) , 910-920
- https://doi.org/10.1038/sj.onc.1204171
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 78 references indexed in Scilit:
- The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein.Genes & Development, 1996
- Transcriptional control by E2FSeminars in Cancer Biology, 1995
- Differential regulation of E2F transactivation by cyclin/cdk2 complexes.Genes & Development, 1994
- Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinaseCell, 1994
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Retinoblastoma protein switches the E2F site from positive to negative elementNature, 1992
- p53, guardian of the genomeNature, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.Genes & Development, 1992